High levels of miR-182 may provide a growth advantage to prostate tumor cells as high levels of miR-182 in patient prostate tumors correlated with poor survival (103), and miR-182 directly targeted the metastasis suppressor 1 (MIM) to increase proliferation of prostate (103) and breast cancer cells (109,110). The gene discussed is MTSS1; the disease is breast carcinoma.